Page last updated: 2024-09-04

esorubicin and Hepatocellular Carcinoma

esorubicin has been researched along with Hepatocellular Carcinoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cnaan, A; Dayal, Y; Falkson, G; Falkson, H; Haller, DG; Simson, IW; Smith, TJ1

Trials

1 trial(s) available for esorubicin and Hepatocellular Carcinoma

ArticleYear
A randomized phase II study of acivicin and 4'deoxydoxorubicin in patients with hepatocellular carcinoma in an Eastern Cooperative Oncology Group study.
    American journal of clinical oncology, 1990, Volume: 13, Issue:6

    Topics: Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Doxorubicin; Drug Administration Schedule; Female; Humans; Isoxazoles; Liver Neoplasms; Male; Prospective Studies; Survival Rate

1990
chemdatabank.com